Cardio Diagnostics Holdings, Inc.
CDIO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $35 | $17 | $1 | $1 |
| % Growth | 104.5% | 1,696.3% | 5.4% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $35 | $17 | $1 | $1 |
| % Margin | 100% | 100% | 100% | 100% |
| R&D Expenses | $29 | $145 | $40 | $31 |
| G&A Expenses | $8,169 | $6,937 | $4,400 | $471 |
| SG&A Expenses | $8,352 | $7,095 | $4,493 | $574 |
| Sales & Mktg Exp. | $182 | $159 | $93 | $103 |
| Other Operating Expenses | $20 | $19 | $16 | $16 |
| Operating Expenses | $8,401 | $7,260 | $4,549 | $621 |
| Operating Income | -$8,366 | -$7,242 | -$4,548 | -$620 |
| % Margin | -23,977.9% | -42,440.4% | -478,784.3% | -68,862.2% |
| Other Income/Exp. Net | -$18 | -$1,134 | -$113 | $0 |
| Pre-Tax Income | -$8,383 | -$8,377 | -$4,661 | -$620 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$8,383 | -$8,377 | -$4,661 | -$620 |
| % Margin | -24,028.2% | -49,087.8% | -490,630% | -68,862.2% |
| EPS | -9.3 | -19.8 | -45.3 | -1.96 |
| % Growth | 53% | 56.3% | -2,211.2% | – |
| EPS Diluted | -9.3 | -19.8 | -45.3 | -1.96 |
| Weighted Avg Shares Out | 26,893 | 423 | 3,088 | 317 |
| Weighted Avg Shares Out Dil | 26,893 | 423 | 3,088 | 317 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $1 | $0 | $0 |
| Interest Expense | $19 | $6,735 | $0 | $0 |
| Depreciation & Amortization | $276 | $112 | $16 | $16 |
| EBITDA | -$8,088 | -$1,530 | -$4,645 | -$604 |
| % Margin | -23,182.8% | -8,966.9% | -488,945.8% | -67,086.3% |